Zusammenfassung
Die Diagnose der ankylosierenden Spondylitis (AS) wird anhand der modifizierten New-York-Kriterien und somit auf der Basis von bereits sichtbaren radiographischen strukturellen Veränderungen gemacht. Konventionelle Röntgenbilder sind allerdings nicht geeignet, entzündliche Prozesse in frühen Erkrankungsphasen rechtzeitig zu erkennen. Die Konsequenz ist, dass der im Verlauf der Erkrankung wichtige Zeitraum, in dem irreversible strukturelle Schäden noch nicht aufgetreten sind, für die Diagnostik verloren geht. Deshalb hat sich mit der Magnetresonanztomographie (MRT), mit der charakteristische entzündliche Läsionen bei Patienten mit axialen und peripheren Spondyloarthritiden (SpA), einschließlich der AS, frühzeitig abgebildet werden können, ein diagnostischer Paradigmenwechsel ergeben. Die Fähigkeit der MRT, entzündliche und, wenn auch begrenzt, strukturelle Veränderungen sichtbar zu machen, begründet den zunehmenden Stellenwert in der Diagnostik von Patienten mit SpA. Zur Erfassung von Strukturschäden gilt aber das konventionelle Röntgenbild immer noch als das Standardverfahren. Daher ist eine vernünftig abgestufte Indikation beider Techniken essenziell für ein optimales Management der Patienten.
Abstract
The diagnosis of ankylosing spondylitis (AS) is based on the modified New York criteria and therefore on defined structural changes in the sacroiliac joint as detected by conventional radiographs. However, x-rays are not able to detect early stages of the disease in which inflammation predominates and irreversible structural changes have not yet taken place. This probably contributes to a substantial time delay until a diagnosis is made. Magnetic resonance imaging (MRI) is able to visualize active and chronic changes in axial and peripheral spondyloarthritis (SpA) even before the occurrence of structural changes. The ability to demonstrate both active and, in a limited way, also structural changes makes MRI a diagnostic tool of increasing importance in the management of SpA. However, conventional radiographs are still the gold standard for the assessment of structural changes in SpA. A combination of both imaging techniques is recommended in clinical practice.
Literatur
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379–1390
Rudwaleit M et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783
Rudwaleit M et al (2006) Inflammatory back pain in ankyolsing spondylitis: a reassessment of the clinical history of application as classification and diagnostic criteria. Ann Rheum 54:569–578
Braun J et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58–67
Braun J, Heijde D van der (2002) Imaging and scoring in ankylosing spondylitis. Best Pract Res Clin Rheumatol 16:573–604
Baraliakos X et al (2007) Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 66:910–915
Baraliakos X et al (2008) The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 10:R104
Puhakka KB et al (2004) MR imaging of the normal sacroiliac joint with correlation to histology. Skeletal Radiol 33:15–28
Braun J et al (2004) Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63:1046–1055
Hermann KG et al (2005) Spinal changes in patients with spondyloarthritis: comparison of MR imaging and radiographic appearances. Radiographics 25:559–569, discussion 569–570
Rudwaleit M et al (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 68:1520–1527
Bollow M et al (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59:135–140
Muche B et al (2003) Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 48:1374–1384
Machado P et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47–53
Heijde D van der et al (2010) Update of the international ASA recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905–908
Rennie WJ et al (2009) Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae. Arthritis Rheum 61:1187–1193
Appel H et al (2006) Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 8:R143
Baraliakos X et al (2005) Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 64:730–734
Baraliakos X et al (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging (MRI): a comparison between contrast enhanced T1 and short-tau inversion recovery (STIR) sequences. Ann Rheum Dis 64:1141–1144
Hermann KG et al (2005) Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary? J Rheumatol 32:2056–2060
Romanus R, Yden S (1952) Destructive and ossifying spondylitic changes in rheumatoid ankylosing spondylitis. Acta Orthop Scand 22:89
Jevtic V et al (2000) Marginal erosive discovertebral „Romanus“ lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging. Skeletal Radiol 29:27–33
Kenny JB, Hughes PL, Whitehouse GH (1990) Discovertebral destruction in ankylosing spondylitis: the role of computed tomography and magnetic resonance imaging. Br J Radiol 63:448–455
Kabasakal Y, Garrett SL, Calin A (1996) The epidemiology of spondylodiscitis in ankylosing spondylitis–a controlled study. Br J Rheumatol 35:660–663
Rudlaweit M et al (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63:535–543
Hermann KG et al (2012) Descriptions of spinal magnetic resonance imaging (MRI) lesions and definition of a positive MRI of the spine in axial spondyloarthritis (SpA) – A consensual approach of the ASAS/OMERACT MRI Study Group. Ann Rheum Dis
Dougados M et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227
Amor B, Dougados M, Mijiyawa M (1990) Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 57:85–89
Linden S van der, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
Heuft-Dorenbosch L et al (2006) Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain. Ann Rheum Dis 65:804–808
Braun A et al (2011) Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain. Ann Rheum Dis
Sieper J, Rudwaleit M (2005) Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis 64:659–663
Cooper C et al (1994) Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 21:1877–1882
Wanders A et al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 52:1756–1765
Sieper J et al (2008) Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 58:649–656
Diarra D et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156–163
Daoussis D et al (2010) Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62:150–158
Appel H et al (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60:3257–3262
Visvanathan S et al (2009) Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 68:175–182
Barkham N et al (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60:946–954
Heijde D van der et al (2011) MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis
Maksymowych WP et al (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 60:93–102
Rudwaleit M et al (2005) Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis before and during therapy with etanercept. Ann Rheum Dis 64:1305–1310
Braun J et al (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48:1126–1136
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baraliakos, X., Braun, J. MRT-Untersuchungen bei axialer und peripherer Spondyloarthritis. Z. Rheumatol. 71, 27–37 (2012). https://doi.org/10.1007/s00393-011-0894-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-011-0894-3
Schlüsselwörter
- Spondyloarthritis
- Ankylosierende Spondylitis
- Magnetresonanztomographie
- Entzündliche Läsionen
- Strukturelle Veränderungen